Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells

Sci Rep. 2016 Feb 22:6:21629. doi: 10.1038/srep21629.

Abstract

The mesenchymal state in cancer is usually associated with poor prognosis due to the metastatic predisposition and the hyper-activated metabolism. Exploiting cell glucose metabolism we propose a new method to detect mesenchymal-like cancer cells. We demonstrate that the uptake of glucose-coated magnetic nanoparticles (MNPs) by mesenchymal-like cells remains constant when the glucose in the medium is increased from low (5.5 mM) to high (25 mM) concentration, while the MNPs uptake by epithelial-like cells is significantly reduced. These findings reveal that the glucose-shell of MNPs plays a major role in recognition of cells with high-metabolic activity. By selectively blocking the glucose transporter 1 channels we showed its involvement in the internalization process of glucose-coated MNPs. Our results suggest that glucose-coated MNPs can be used for metabolic-based assays aimed at detecting cancer cells and that can be used to selectively target cancer cells taking advantage, for instance, of the magnetic-thermotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Epithelial Cells / drug effects
  • Epithelial Cells / pathology
  • Female
  • Glucose / administration & dosage*
  • Glucose / chemistry
  • Glucose / metabolism
  • Glucose Transporter Type 1 / antagonists & inhibitors
  • Glucose Transporter Type 1 / genetics*
  • Humans
  • Hyperthermia, Induced
  • MCF-7 Cells
  • Magnetite Nanoparticles / administration & dosage*
  • Magnetite Nanoparticles / chemistry
  • Mesoderm / metabolism
  • Mesoderm / pathology

Substances

  • Glucose Transporter Type 1
  • Magnetite Nanoparticles
  • SLC2A1 protein, human
  • Glucose